Mumbai: The US tariffs on India is a “wrong approach”, said Phil Murphy, governor of New Jersey and a senior Democratic party leader. On a recent visit to India, Murphy’s delegation focused on economic growth, government-level relations and collaboration for higher education. He emphasised India’s strong position as a key business ally for the US….
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump’s move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines. Reacting to the development, IPA Secretary General Sudarshan Jain said in a statement, “It is not applicable to generics medicines.”…
New Delhi: Pharmaceuticals Export Promotion Council of India (Pharmexcil) on Thursday said President Donald Trump’s imposition of a 25 per cent tariff plus unspecified penalty on all goods coming from India starting August 1, will result in increased costs for essential drugs in the US, ultimately harming consumers and healthcare systems in the country in…